Inventor · disambiguated record
Ananda Chakrabarty
Also filed as: CHAKRABARTY ANANDA · CHAKRABARTY ANANDA M
46 granted patents·5 pending applications·512 citations·filing 1972–2018
98Inventor score
Top patents by PatentIndex Score
51 records- 0198US8017749B2Compositions and methods to treat cancer with cupredoxins and CpG rich DNAUNIV ILLINOIS·Filed 2007·Granted Sep 13, 2011·36 cites·15 claims
- 0297US7691383B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2005·Granted Apr 6, 2010·41 cites·32 claims
- 0396US7338766B2Compositions and methods for treating malaria with cupredoxin and cytochromeUNIV ILLINOIS·Filed 2006·Granted Mar 4, 2008·40 cites·8 claims
- 0496US7301010B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2006·Granted Nov 27, 2007·33 cites·23 claims
- 0595US7381701B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsUNIV ILLINOIS·Filed 2006·Granted Jun 3, 2008·24 cites·5 claims
- 0694US8530635B2Cupredoxin derived transport agents and methods of use thereofCHAKRABARTY ANANDA·Filed 2012·Granted Sep 10, 2013·10 cites·36 claims
- 0794US8232244B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2008·Granted Jul 31, 2012·15 cites·46 claims
- 0894US7807183B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2006·Granted Oct 5, 2010·23 cites·22 claims
- 0993US8206685B2Cupredoxin derived transport agents and methods of use thereofCHAKRABARTY ANANDA·Filed 2010·Granted Jun 26, 2012·9 cites·5 claims
- 1092US7511117B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2007·Granted Mar 31, 2009·16 cites·7 claims
- 1192US4535061ABacteria capable of dissimilation of environmentally persistent chemical compoundsUNIV ILLINOIS·Filed 1981·Granted Aug 13, 1985·63 cites·2 claims
- 1291US7556810B2Compositions and methods to control angiogenesis with cupredoxinsUNIV ILLINOIS·Filed 2006·Granted Jul 7, 2009·16 cites·5 claims
- 1390US8227402B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2009·Granted Jul 24, 2012·7 cites·15 claims
- 1490US7084105B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2002·Granted Aug 1, 2006·33 cites·23 claims
- 1589US7740857B2Compositions and methods for treating malaria with cupredoxin and cytochromeUNIV ILLINOIS·Filed 2008·Granted Jun 22, 2010·7 cites·8 claims
- 1688US10117905B2Compositions and methods to prevent cancer with cupredoxinsUNIV ILLINOIS·Filed 2015·Granted Nov 6, 2018·2 cites·11 claims
- 1788US9161989B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2013·Granted Oct 20, 2015·4 cites·11 claims
- 1888US7618939B2Compositions and methods to prevent cancer with cupredoxinsUNIV ILLINOIS·Filed 2007·Granted Nov 17, 2009·11 cites·13 claims
- 1985US10058585B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereofUNIV ILLINOIS·Filed 2015·Granted Aug 28, 2018·3 cites·8 claims
- 2085US4259444AMicroorganisms having multiple compatible degradative energy-generating plasmids and preparation thereofGEN ELECTRIC·Filed 1972·Granted Mar 31, 1981·36 cites·18 claims
- 2184US9969781B2Compositions and methods to treat cancer with CpG rich DNA and cupredoxinsDAS GUPTA TAPAS·Filed 2011·Granted May 15, 2018·2 cites·8 claims
- 2284US9309292B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2013·Granted Apr 12, 2016·4 cites·19 claims
- 2384US9107881B2Compositions and methods to control angiogenesis with cupredoxinsUNIV ILLINOIS·Filed 2013·Granted Aug 18, 2015·5 cites·32 claims
- 2484US8545812B2Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereofHONG CHANG SOO·Filed 2012·Granted Oct 1, 2013·6 cites·16 claims
- 2584US7888468B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2006·Granted Feb 15, 2011·6 cites·8 claims
- 2682US9096663B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereofCHAUDHARI ANITA·Filed 2008·Granted Aug 4, 2015·4 cites·5 claims
- 2782US8623816B2Compositions and methods for treating malaria with cupredoxin and cytochromeCHAKRABARTY ANANDA·Filed 2007·Granted Jan 7, 2014·3 cites·2 claims
- 2882US7491394B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2003·Granted Feb 17, 2009·14 cites·3 claims
- 2981US10590177B2Modifications of cupredoxin derived peptidesUNIV ILLINOIS·Filed 2018·Granted Mar 17, 2020·2 cites·5 claims
- 3081US10239920B2Cupredoxin derived transport agents and methods of use thereofUNIV ILLINOIS·Filed 2015·Granted Mar 26, 2019·2 cites·10 claims
- 3181US9134298B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2012·Granted Sep 15, 2015·2 cites·9 claims
- 3280US8372962B2Compositions and methods to control angiogenesis with cupredoxinsUNIV ILLINOIS·Filed 2012·Granted Feb 12, 2013·3 cites·2 claims
- 3379US10086037B2Compositions and methods to prevent cancer with cupredoxinsDAS GUPTA TAPAS·Filed 2012·Granted Oct 2, 2018·2 cites·11 claims
- 3479US9957304B2Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsCHAKRABARTY ANANDA·Filed 2008·Granted May 1, 2018·2 cites·8 claims
- 3578US10889621B2Compositions and methods for treating conditions related to ephrin signaling with CupredoxinsUNIV ILLINOIS·Filed 2018·Granted Jan 12, 2021·1 cites·13 claims
- 3678US8188251B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofHONG CHANG SOO·Filed 2010·Granted May 29, 2012·3 cites·6 claims
- 3777US10005821B2Modifications of cupredoxin derived peptides and methods of use thereofDAS GUPTA TAPAS·Filed 2007·Granted Jun 26, 2018·2 cites·50 claims
- 3876US7795410B2Compositions and methods for treating HIV infection with cupredoxin and cytochrome cUNIV ILLINOIS·Filed 2009·Granted Sep 14, 2010·3 cites·17 claims
- 3975US10421801B2Cytotoxic factors for modulating cell deathUNIV ILLINOIS·Filed 2013·Granted Sep 24, 2019·2 cites·5 claims
- 4075US8124055B2Compositions and methods to control angiogenesis with cupredoxinsMEHTA RAJESHWARI R·Filed 2009·Granted Feb 28, 2012·3 cites·14 claims
- 4168US10266868B2Compositions for treating HIV infection with cupredoxin and cytochrome CCHAKRABARTY ANANDA·Filed 2010·Granted Apr 23, 2019·1 cites·7 claims
- 4267US11046733B2Compositions and methods to treat cancer with CpG rich DNA and cupredoxinsUNIV ILLINOIS·Filed 2017·Granted Jun 29, 2021·0 cites·5 claims
- 4356US10072049B2Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereofUNIV ILLINOIS·Filed 2016·Granted Sep 11, 2018·0 cites·8 claims
- 4453US10266573B2Cytotoxic factors for modulating cell deathCHAKRABARTY ANANDA M·Filed 2008·Granted Apr 23, 2019·0 cites·6 claims
- 4551US2009208476A1Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxinsDAS GUPTA TAPAS·Filed 2008·Application pending·0 cites
- 4650US2008182782A1Cytotoxic factors for modulating cell deathCHAKRABARTY ANANDA M·Filed 2006·Application pending·0 cites
- 4748US2014287990A1Compositions and methods to concurrently treat and/or prevent multiple diseases with cupredoxinsUNIV ILLINOIS·Filed 2013·Application pending·0 cites
- 4848US2007129300A1Cytotoxic factors for modulating cell deathCHAKRABARTY ANANDA M·Filed 2006·Application pending·0 cites
- 4939US5013654AProduction of emulsifying agents and surfactantsUNIV ILLINOIS·Filed 1990·Granted May 7, 1991·11 cites·4 claims
- 5033US2010278937A1Compositions and methods to prevent and/or treat cancer with pa-cardDAS GUPTA TAPAS K·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ananda Chakrabarty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →